Grant Pickering
Founder presso VAXCYTE, INC.
Patrimonio netto: 53 M $ in data 31/03/2024
Posizioni attive di Grant Pickering
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VAXCYTE, INC. | Director/Board Member | 27/05/2013 | - |
| Chief Executive Officer | 27/05/2013 | - | |
| Founder | 27/05/2013 | - | |
| President | 27/05/2013 | 01/01/2021 | |
| ATHIRA PHARMA, INC. | Director/Board Member | 27/01/2022 | - |
| Independent Dir/Board Member | 27/01/2022 | - |
Storia della carriera di Grant Pickering
Precedenti posizioni note di Grant Pickering
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MYMETICS CORPORATION | Director/Board Member | 22/03/2012 | 19/11/2012 |
| Chief Executive Officer | 22/03/2012 | 19/11/2012 | |
| President | 22/03/2012 | 19/11/2012 | |
| DENDREON CORPORATION | Chief Operating Officer | - | 18/11/2005 |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Director/Board Member | 14/03/2008 | - |
| Chief Executive Officer | 14/03/2008 | - | |
| President | 14/03/2008 | - |
Formazione di Grant Pickering
| The Pennsylvania State University | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
- Borsa valori
- Insiders
- Grant Pickering
- Esperienza
